Porphysome Mediated Drug Delivery and PET Imaging to Enhance Adoptive Double Negative T-cell Therapy for Non-Small Cell Lung Cancer Treatment
Porphysome Mediated Drug Delivery and PET Imaging to Enhance Adoptive Double Negative T-cell Therapy for Non-Small Cell Lung Cancer Treatment
卟啉体介导的药物递送和 PET 成像增强过继性双阴性 T 细胞疗法治疗非小细胞肺癌
批准号：
362492
负责人：
Lou Jenny
金额：
$10.93万
依托单位：
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-11-01 至 2019-11-01
中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Since the leading cause of cancer death worldwide is lung cancer and its 5 year survival rate is <20% adjuvant treatments are needed. Immunotherapy is promising because it can improve patient survival. However, to improve immunotherapy, we need to underst
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Porphysome mediated delivery of interleukin-2 and in vivo tracking of double negative T-cells for adoptive cell therapy to treat acute myeloid leukemia
-
批准号：350013
-
项目类别：Studentship Programs
-
资助金额：$1.27万
-
财政年份：2015
-
负责人：Lou Jenny
-
依托单位：
海外基金
